Ohio State team spots potential new fibromyalgia biomarkers; Life Tech brings biomarker expertise to companion Dx deal;

> Life Technologies ($LIFE) brings newly acquired biomarker expertise to its companion diagnostics collaboration deal with Merck Serono, putting into play technology it snatched up last October. Story

> Ohio State researchers developing a new fibromyalgia blood test say they've identified potential new biomarkers for the condition. More

> NEBA Health's new brain wave diagnostic for ADHD, which relies on a combined biomarker and clinical evaluation, won FDA clearance, in part, by proving the test is more accurate than clinical evaluation alone. Item

> Array BioPharma ($ARRY) is seeking a partner to fund further studies of its oral CRTH2 antagonist after promising Phase II results in patients with allergic asthma. Story

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.